A randomized phase III trial of Paraplatin (carboplatin) + Gemzar [gemcitabine] versus Gemzar alone in patients wtih advanced non-small cell lung cancer
Phase of Trial: Phase III
Latest Information Update: 03 Nov 2009
At a glance
- Drugs Carboplatin; Gemcitabine
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 03 Nov 2009 Results published in the Journal of Clinical Oncology.
- 10 Nov 2007 Status change from in progress to completed.
- 19 Jan 2007 Status changed from recruiting